These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38725586)

  • 1. Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience.
    Zona EE; Gibes ML; Jain AS; Danobeitia JS; Garonzik-Wang J; Smith JA; Mandelbrot DA; Parajuli S
    Crit Care Res Pract; 2024; 2024():7140548. PubMed ID: 38725586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Kidney Injury in a Predominantly African American Cohort of Kidney Transplant Recipients With COVID-19 Infection.
    Shrivastava P; Prashar R; Khoury N; Patel A; Yeddula S; Kitajima T; Nagai S; Samaniego M
    Transplantation; 2021 Jan; 105(1):201-205. PubMed ID: 33093403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center.
    Mikhailov M; Budde K; Halleck F; Eleftheriadis G; Naik MG; Schrezenmeier E; Bachmann F; Choi M; Duettmann W; von Hoerschelmann E; Koch N; Liefeldt L; Lücht C; Straub-Hohenbleicher H; Waiser J; Weber U; Zukunft B; Osmanodja B
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37763043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Course, Management and Outcomes in Kidney Transplant Recipients with SARS-CoV-2 Infection during the Omicron-Variant Wave: A Single-Center Experience.
    Korogiannou M; Vallianou K; Xagas E; Rokka E; Soukouli I; Boletis IN; Marinaki S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients.
    Han A; Min S; Jo EA; Lee H; Kim YC; Han SS; Kang HG; Ahn YH; Oh I; Song EY; Ha J
    Ann Lab Med; 2024 Jan; 44(1):64-73. PubMed ID: 37665287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
    Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
    Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease.
    Bezerra R; Feitosa ADM; Silvestre OM; Fernandes-Silva MM; Amazonas RB; Teles F; Rodrigues CIS; Lima-Filho JL; Sposito AC; Nadruz W
    Ann Med; 2024 Dec; 56(1):2343890. PubMed ID: 38738416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
    Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
    Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
    Solera JT; Árbol BG; Mittal A; Hall VG; Marinelli T; Bahinskaya I; Humar A; Kumar D
    Transplantation; 2024 May; 108(5):1249-1256. PubMed ID: 38291585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of COVID‑19 in hospitalized kidney and liver transplant recipients: a single‑center experience.
    Ślusarczyk A; Tracz A; Gronkiewicz M; Jureczko L; Bączkowska T
    Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34351090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients.
    Zhang X; Weng R; Liu F; Xie Y; Jin Y; Li Q; Huang G; Chen J; Wang J; Shen H; Fu H; Mao J
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Hanoy M; Laurent C; Lebourg L; Etienne I; Lemoine M; Le Roy F; Nezam D; Plantier JC; Boyer O; Guerrot D; Candon S
    J Am Soc Nephrol; 2021 Sep; 32(9):2147-2152. PubMed ID: 34112706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Scoping Review of the Impact of COVID-19 on Kidney Transplant Patients in the United States.
    Karas M; Bernal I; Diaz O; Alshammari O; Baggett D; Bronk T; Chawdhury S; Eylon A; Garcia E; Haughton K; Kothe B; Joseph AM; Jacobs RJ
    Cureus; 2023 Mar; 15(3):e35725. PubMed ID: 37025740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability-Does One Exist?
    Virmani S; Gleeson SE; Girone GF; Malhotra D; Cohen EA; Klarman SE; Asch WS
    Transplant Proc; 2020 Nov; 52(9):2584-2591. PubMed ID: 32711848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.